Meeder Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-272	Closed	-$5.24K	–	1012
2024 Q3	$5.24K	Buy	272 +59	+28%	+$1.22K	﹤0.01%	735
2024 Q2	$4.37K	Buy	213 +27	+15%	+$565	﹤0.01%	794
2024 Q1	$4.43K	Buy	+186	New	+$4.15K	﹤0.01%	646
2020 Q3	–	Sell	-59	Closed	–	–	2359
2020 Q2	$0	Sell	59 -901	-94%	-$13.7K	﹤0.01%	2430
2020 Q1	$11K	Sell	960 -183	-16%	-$1.72K	﹤0.01%	1484
2019 Q4	$9K	Buy	1,143 +520	+83%	+$3.82K	﹤0.01%	1596
2019 Q3	$5K	Buy	623 +126	+25%	+$1.15K	﹤0.01%	1776
2019 Q2	$5K	Buy	497 +246	+98%	+$1.79K	﹤0.01%	1679
2019 Q1	$1K	Buy	+251	New	+$1.43K	﹤0.01%	1641
2018 Q4	–	Sell	-202	Closed	-$2K	–	1793
2018 Q3	$2K	Buy	+202	New	+$1.44K	﹤0.01%	1444
2018 Q2	–	Sell	-145	Closed	-$2K	–	1672
2018 Q1	$2K	Buy	+145	New	+$1.54K	﹤0.01%	1393
2017 Q3	–	Sell	-219	Closed	-$3K	–	1751
2017 Q2	$3K	Sell	219 -3	-1%	-$34	﹤0.01%	1337
2017 Q1	$3K	Buy	222 +6	+3%	+$62	﹤0.01%	1278
2016 Q4	$2K	Buy	+216	New	+$2.37K	﹤0.01%	937